Epstein-Barr virus seroprevalence among inflammatory bowel disease patients in Saudi Arabia.
Badr Al-BawardyAbdulaziz F AlfadleyMohammed AlmousallamSaad AlShathriMohamed AboueissaAbdulrahman AlsulaimanMashary AttamimiAbdulelah AlMutairdiPublished in: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association (2024)
In our cohort of IBD patients, 16.8% were naïve to EBV, and young age was a significant predictor of EBV non-exposure. Our data supports the practice of assessing EBV before initiating thiopurine therapy since EBV seroprevalence is not universal in our population.
Keyphrases
- epstein barr virus
- diffuse large b cell lymphoma
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- primary care
- peritoneal dialysis
- machine learning
- patient reported outcomes
- stem cells
- mesenchymal stem cells
- big data
- artificial intelligence
- patient reported
- cell therapy
- ulcerative colitis